Prognostic factors for local control of stage I non-small cell lung cancer in stereotactic radiotherapy: A retrospective analysis

Radiation Oncology

Volumn 7, Issue 1, 2012, Pages

  Shirata, Yuko ^a   Jingu, Keiichi ^a   Koto, Masashi ^b   Kubozono, Masaki ^a   Takeda, Ken ^a   Sugawara, Toshiyuki ^a   Kadoya, Noriyuki ^a   Matsushita, Haruo ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

Author keywords

Minimum dose; Non small cell lung cancer; NSCLC; Prognostic factor; PTV margin; SBRT; Stereotactic radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROGNOSIS; RADIATION DOSE; RADIATION FIELD; RETROSPECTIVE STUDY; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT OUTCOME; TREATMENT PLANNING;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RADIOSURGERY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84868247562     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-7-182     Document Type: Article

References (26)

1. Buyyounouski MK, Balter P, Lewis B, et al. Stereotactic body radiotherapy for early-stage non-small-cell lung cancer: report of the ASTRO emerging technology committee. Int J Radiat Oncol Biol Phys 2010, 78:3-10. 10.1016/j.ijrobp.2010.04.010, 20643514.
2. Onimaru R, Fujino M, Yamazaki K, et al. Steep dose-response relationship for stage I non-small-cell lung cancer using hypofractionated high-dose irradiation by real-time tumor-tracking radiotherapy. Int J Radiat Oncol Biol Phys 2008, 70:374-381. 10.1016/j.ijrobp.2007.06.043, 18029106.
3. Onishi H, Shirato H, Nagata Y, et al. Hypofractionated Stereotactic Radiotherapy (HypoFXSRT) for Stage I Non-small cell lung cancer: Updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol 2007, 2:S94-S100. 10.1097/JTO.0b013e318074de34, 17603311.
4. Asamura H, Goya T, Koshiishi Y, et al. A Japanese Lung Cancer Registry Study: Prognosis of 13010 Resected Lung Cancers. J Thorac Oncol 2007, 3:46-52.
5. Willard AF, Jerri LP, Herman RM. Ten-year survey of lung cancer treatment and survival in hospitals in the United States. A national cancer data base report. Cancer 1999, 86(9):1867-1876. 10.1002/(SICI)1097-0142(19991101)86:9<1867::AID-CNCR31>3.0.CO;2-9, 10547562.
6. Aberle DR, Adams AM, Berq CD, Black WC, Clapp JD, Faqerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD, National Lung Screening Trial Research Team Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011, 365(5):395-409. National Lung Screening Trial Research Team.
7. Nagata Y, Takayama K, Matsuo Y, Norihisa Y, Mizowaki T, Sakamoto T, Sakamoto M, Mitsumori M, Shibuya K, Araki N, Yano S, Hiraoka M. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2005, 63(5):1427-1431. 10.1016/j.ijrobp.2005.05.034, 16169670.
8. Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, Bradley J, Fakiris A, Bezjak A, Videtic G, Johnstone D, Fowler J, Gore E, Choy H. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010, 303(11):1070-1076. 10.1001/jama.2010.261, 2907644, 20233825.
9. Fakiris AJ, McGarry RC, Yiannoutsos CT, Papiez L, Williams M, Henderson MA, Timmerman R. Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study. Int J Radiat Oncol Biol Phys 2009, 75(3):677-682. 10.1016/j.ijrobp.2008.11.042, 19251380.
10. Koto M, Takai Y, Ogawa Y, Matsushita H, Takeda K, Takahashi C, Britton KR, Jingu K, Takai K, Mitsuya M, Nemoto K, Yamada S. A phase II study on stereotactic body radiotherapy for stage I non-small cell lung cancer. Raditother Oncol 2007, 85(3):429-434.
11. Shiono S, Abiko M, Sato T. Positron emission tomography/computed tomography and lymphovascular invasion predict recurrence in stage I lung cancers. J Thorac Oncol 2010, 6:43-47.
12. Takeda A, Kunieda E, Shigematsu N, Hossain DM, Kawase T, Ohashi T, Fukada J, Kawaguchi O, Uematsu M, Takeda T, Takemasa K, Takahashi T, Kubo A. Small lung tumors: long-scan -time CT for planning of hypofractionated stereotactic radiation therapy-initial findings. Radiology 2005, 237:295-300. 10.1148/radiol.2371032102, 16118151.
13. Matsuo Y, Shibuya K, Nagata Y, Takayama K, Norihisa Y, Mizowaki T, Narabayashi M, Sakanaka K, Hiraoka M. Prognostic factors in stereotactic body radiotherapy for non-small -cell lung cancer. Int J Radiat Oncol Biol Phys 2011, 79:1104-1111. 10.1016/j.ijrobp.2009.12.022, 20472343.
14. Koike T, Tsuchiya R, Goya T, Sohara Y, Miyaoka E. Prognostic factors in 3315 Completely Resected Cases of Clinical Stage I Non-small Cell Lung Cancer in Japan. J Thorac Oncol 2007, 2:408-413. 10.1097/01.JTO.0000268674.02744.f9, 17473656.
15. Baumann P, Nyman J, Lax I, Friesland S, Hoyer M, Ericsson SR, Johansson KA, Ekberg L, Morhed E, Paludan M, Wittgren L, Blomgren H, Lewensohn R. Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries. Acta Oncol 2006, 45:787-795. 10.1080/02841860600904862, 16982541.
16. Fowler JF, Tomé WA, Fenwick JD, Mehta MP. A challenge to traditional radiation oncology. Int J Radiat Oncol Biol Phys 2004, 60:1241-1256. 10.1016/j.ijrobp.2004.07.691, 15519797.
17. Brunner TB, Kunz-Schughart LA, Grosse-Gehling P, Baumann M. Cancer Stem Cells as a Predictive Factor in Radiotherapy. Semin Radiat Oncol 2012, 22:151-174. 10.1016/j.semradonc.2011.12.003, 22385922.
18. Matsuo Y, Shibuya K, Nagata Y, Norihisa Y, Narabayashi M, Sakanaka K, Ueki N, Mizowaki T, Hiraoka M. Preliminary Report of Late Recurrences, at 5 Years or more, after Stereotactic Body Radiation Therapy for Non-small Cell Lung Cancer. J Thorac Oncol 2012, 7:453-456. 10.1097/JTO.0b013e31823c5b29, 22252562.
19. Baba F, Shibamoto Y, Ogino H, Murata R, Sugie C, Iwata H, Otsuka S, Kosaki K, Nagai A, Murai T, Miyakawa A. Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size. Radiat Oncol 2010, 5(81):1-7. 2823752, 20070901.
20. Shibamoto Y, Otsuka S, Iwata H, Sugie C, Ogino H, Tomita N. Radiobiological Evaluation of the Radiation Dose as Used in High-precision Radiotherapy: Effect of Prolonged Delivery Time and Applicability of the Linear-quadratic Model. J Radiat Res 2012, 53:1-9. 10.1269/jrr.11095, 21997195.
21. Zhang J, Yang F, Li B, Li H, Liu J, Huang W, Wang D, Yi Y, Wang J. Which is the optimal biological effective dose of stereotactic body radiotherapy for stage I non-small-cell lung cancer? A meta-analysis. Int J Radiat Oncol Biol Phys 2011, 81:e305-e316. 10.1016/j.ijrobp.2011.04.034, 21658853.
22. Chi A, Liao Z, Nguyen NP, Xu J, Stea B, Komaki R. Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: Clinical implications. Radiat Oncol 2010, 94:1-11.
23. Baumann P, Nyman J, Hoyer M, Wennberg B, Gagliardi G, Lax I, Drugge N, Ekberg L, Friesland S, Johansson KA, Lund J, Morhed E, Nilsson K, Levin N, Paludan M, Sederholm C, Traberg A, Wittgren L, Lewensohn R. Outcome in a Prospective Phase II Trial of Medically Inoperable Stage I Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiotherapy. J Clin Oncol 2009, 27:3290-3296. 10.1200/JCO.2008.21.5681, 19414667.
24. Wulf J, Baier K, Mueller G, Flentje MP. Dose-response in stereotactic irradiation of lung tumors. Radiat Oncol 2005, 77:83-87.
25. Lax I, Panettieri V, Berit W, et al. Dose-distributions in SBRT of lung tumors: Comparison between two different treatment planning algorithms and Monte-Carlo simulation including breathing motions. Acta Oncol 2006, 45:978-988. 10.1080/02841860600900050, 16982567.
26. Yamashita H, Nakagawa K, Nakamura N, Duch MA, Näslund I, Baumann P, Gagliard G. Exceptionally high incidence of symptomatic grade 2-5 radiation pneumonitis after stereotactic radiation therapy for lung tumors. Radiat Oncol 2007, 2:1-11. 10.1186/1748-717X-2-1, 1770925, 17201910.